What's breaking now, across thousands of outlets.
The FDA has approved the third treatment for a debilitating genetic disease that turns muscle and connective tissue to bone. Mirum Pharmaceuticals’ zilurgisertib, which blocks the ALK2 receptor, will be marketed as Atebrioz for patients ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The highly pathogenic H5N1 avian influenza virus could pose a high risk as a source of a future pandemic, as its spread across birds and mammals continues to expand, a leading infectious disease…
The No Surprises Act has made significant strides in protecting patients from large, unexpected medical bills. Unfortunately, the same cannot be said for the NSA’s promise to protect payments to…
The province has hired 17 psychiatrists this year in an attempt to alleviate pressure on hospital emergency rooms. “Too often, people in crisis end up in the emergency room because […]
Kenya’s proposed Tobacco Control (Amendment) Bill has triggered competing demands from tobacco traders, farmers, regulators and consumers, exposing sharp differences over new licensing requirements…
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
